Author

Preet Kumar

Sylvester Comprehensive Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Abdessamad Youssfi AlaouiiD· 1 shared Alicia Bilbao-Martinez· 1 shared Anna Kingham· 1 shared Artavazd Arumov· 1 shared Austin D. Newsam· 1 shared Bassel AwadaiD· 1 shared Brian B. Silver· 1 shared Caroline A. CoughliniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abdessamad Youssfi AlaouiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The cyclin-G associated kinase (GAK) is a novel mitotic kinase and therapeutic target in diffuse large B-cell lymphoma

Olivia Barbara Farag, Bassel Awada, Abdessamad Youssfi Alaoui, Paola Manara, Anna Kingham, Preet Kumar, Lingxiao Li, Brian B. Silver, Toral Shastri, Santiago Vilar, Austin D. Newsam, Marianna Lekakis, Diego E. Hernandez Parets, Pierre A. Younes, Dhanvantri Chahar, , Jonathan Harry Schatz

This paper identifies GAK as a novel mitotic kinase and therapeutic target in DLBCL, showing that GAK inhibition causes mitotic defects and that existing drugs can be repurposed for its targeting.

Leukemia · Nov 2, 2026Peer-reviewedCancer Biology